2013 annual financial data
TG Therapeutics 2013 Financial results
Direct answer
Revenue was 152,381 USD.
Operating income was -22,965,989 USD and net income was -20,478,210 USD.
Operating cash flow was -10,824,231 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 152,381 USD
- Operating income
- -22,965,989 USD
- Net income
- -20,478,210 USD
- Operating cash flow
- -10,824,231 USD
Explore related company data
View all 2013 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all TG Therapeutics financial years